Alferez, Drix Matthew M.
HRN: 27-52-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2025
MUPIROCIN 2%, 15G (TUBE)
11/05/2025
11/11/2025
TOPICAL
-
BID
Phlebitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes